374 related articles for article (PubMed ID: 29286073)
1. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
2. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
3. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
Kim MH; Lee EJ; Kim SJ; Jung YJ; Park WJ; Park I
PLoS One; 2023; 18(6):e0287146. PubMed ID: 37310967
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
6. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
7. Medium-chain fatty acids reduce serum cholesterol by regulating the metabolism of bile acid in C57BL/6J mice.
Liu Y; Zhang Y; Zhang X; Xu Q; Yang X; Xue C
Food Funct; 2017 Jan; 8(1):291-298. PubMed ID: 28009872
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
Kim HJ; Kim JS; Oh S; Yoo HS
Dig Dis; 2017; 35(5):439-443. PubMed ID: 28268212
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
[TBL] [Abstract][Full Text] [Related]
12. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
13. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet.
Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
Lipids Health Dis; 2019 Dec; 18(1):218. PubMed ID: 31829191
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
18. Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota.
Shen S; Huang D; Qian S; Ye X; Zhuang Q; Wan X; Dong Z
Eur J Pharmacol; 2023 Sep; 955():175891. PubMed ID: 37429516
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.
Xie Y; Blanc V; Kerr TA; Kennedy S; Luo J; Newberry EP; Davidson NO
J Biol Chem; 2009 Jun; 284(25):16860-16871. PubMed ID: 19386592
[TBL] [Abstract][Full Text] [Related]
20. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
